Made by SterisWHO-GMP

Vogligold M 0.3

by Steris Healthcare Pvt. Ltd.

Be the first to review

Voglibose 0.3 mg + Metformin Hydrochloride 500 mg

Vogligold M 0.3 is a Schedule H prescription tablet from Steris Healthcare Pvt. Ltd. in the Diabetes category. Each tablet contains Voglibose 0.3 mg and Metformin Hydrochloride 500 mg. It is an oral antidiabetic combination to be used when prescribed by a qualified healthcare professional.

View medicine information ↓
Choose a pack
₹78.09₹111.5530% offinclusive of all taxes
Subscribe & save 5%Refill on your schedule · skip or cancel anytimeSave ₹3.90 every delivery
Set up autopay

Delivery estimate appears here

ManufacturerSteris Healthcare Pvt. Ltd.
Manufacturing qualityWHO-GMP verified
Expiry policyMinimum 3 months
ReviewedClinical review pending

Medicine information

Uses & overview

Vogligold M 0.3 is a tablet in the Diabetes category, manufactured by Steris Healthcare Pvt. Ltd. It is classified as a Schedule H medicine, which means it is intended to be used on the prescription of a registered medical practitioner. Composition: Each tablet contains Voglibose 0.3 mg and Metformin Hydrochloride 500 mg. The catalogue description identifies the metformin component as a sustained-release (SR) form. How the ingredients are described: Voglibose is described as an alpha-glucosidase inhibitor that slows the digestion and absorption of carbohydrates in the intestine, which helps reduce the rise in blood glucose after meals. Metformin belongs to the biguanide class of antidiabetic medicines. It is described as helping reduce glucose production in the liver and improving the body's sensitivity to insulin, with the sustained-release formulation designed to release the medicine gradually. Use: The product information describes this combination as an oral antidiabetic medicine that may be prescribed to help manage blood glucose levels in adults with type 2 diabetes mellitus when the combination is suitable. It is described as part of a broader diabetes care plan that includes dietary management, regular physical activity, blood glucose monitoring and follow-up consultations. Product details: Brand name Vogligold M 0.3; dosage form Tablet; category Diabetes; manufacturer Steris Healthcare Pvt. Ltd.; prescription schedule H. This medicine should be used only as directed by a qualified healthcare professional.

How to use

Take VOGLIGOLD M 0.3 Tablets exactly as prescribed by your doctor. Follow the recommended dosage, timing, and meal-related instructions provided by your healthcare professional and the approved product leaflet. Because the tablet contains sustained-release Metformin, swallow it whole with water. Do not crush, chew, or split the tablet unless the approved product instructions specifically permit this. Voglibose is commonly taken immediately before meals, but follow the directions provided for your prescribed combination product. Do not change the dose or stop treatment without medical advice. Monitor your blood glucose as recommended and attend regular follow-up appointments. Inform your doctor if you experience persistent digestive discomfort or other unexpected symptoms.

Storage

Store VOGLIGOLD M 0.3 Tablets according to the storage instructions printed on the product packaging. Keep the tablets in their original packaging and protect them from excessive heat and moisture. Keep the medicine out of reach of children. Do not use the tablets after their expiry date or if the packaging is damaged.

Important guidance

Safety advice

Check with your doctor
AlcoholConsult your doctor

Avoid excessive alcohol consumption because it may increase the risk of metformin-associated lactic acidosis.

PregnancyConsult your doctor

Consult your doctor if you are pregnant, planning pregnancy, or suspect pregnancy. Your diabetes treatment may need reassessment.

BreastfeedingConsult your doctor

Seek medical advice before using this combination while breastfeeding.

DrivingConsult your doctor

Digestive discomfort or low blood sugar, particularly when used with other antidiabetic medicines, may affect driving ability.

KidneyConsult your doctor

Inform your doctor about kidney disease. Kidney function must be assessed before and during Metformin treatment as appropriate.

LiverConsult your doctor

Inform your doctor about liver disease because it may affect treatment suitability and the risk of lactic acidosis.

Clinical review pending

This page uses verified catalogue facts and responsible medicine-information rules. It supports awareness and does not replace a doctor's advice.

Customer feedback

Ratings & reviews

Be the first to review this product.

Loading reviews…

Write a review

Customers with a delivered order for this product can share their experience. Honest feedback of any rating is welcome.

0/3000 charactersChecking your sign-in status…

Frequently viewed together

OTC
Steris Folic Acid 26 product pack

Steris Folic Acid 26

Strip of 20 units

Folic Acid 100 mg

No reviews
₹89.10₹101.2512% off
OTC
Steris Folic Acid 86 product pack

Steris Folic Acid 86

Strip of 20 units

Folic Acid 100 mg

No reviews
₹155.10₹176.2512% off
Rx · H
Gliempaflozin Met Er 25 And 1000 product pack

Gliempaflozin Met Er 25 And 1000

For 10 Tablets

Empagliflozin 25 mg + Metformin Hydrochloride 1000 mg

No reviews
₹161.21₹230.3030% off
Prescription required before dispatch

Let’s help you order

Speak to our team about medicine availability, prescriptions or your order.

Opens your device’s calling app.